Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ACFE | ISIN: SE0007871363 | Ticker-Symbol: 7VS
Frankfurt
22.01.25
08:02 Uhr
47,740 Euro
+0,900
+1,92 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
VITEC SOFTWARE GROUP AB Chart 1 Jahr
5-Tage-Chart
VITEC SOFTWARE GROUP AB 5-Tage-Chart
RealtimeGeldBriefZeit
48,02048,12009:56
48,04048,10009:53
GlobeNewswire (Europe)
245 Leser
Artikel bewerten:
(1)

Vitec Software Group AB: Vitec Software Group Interim report January-June 2024

Finanznachrichten News

SUMMARY OF INTERIM PERIOD, APRIL-JUNE 2024

  • Net sales SEK 882 million (724), an increase of 22%
  • Recurring revenues SEK 775 million (612), an increase of 27%
  • EBITA SEK 264 million (226), an increase of 17%
  • EBITA margin 30% (31)
  • Operating profit SEK 196 million (164), an increase of 20%
  • Operating margin 22% (23)
  • Earnings per share before dilution SEK 3.18 (2.59)
  • Cash flow from operating activities SEK 89 million (80)
  • Acquisition of Bidtheatre

SUMMARY OF INTERIM PERIOD, JANUARY-JUNE 2024

  • Net sales SEK 1,598 million (1,336), an increase of 20%
  • Recurring revenues SEK 1,391 million (1,121), an increase of 24%
  • EBITA SEK 484 million (412), an increase of 18%
  • EBITA margin 30% (31)
  • Operating profit SEK 349 million (286), an increase of 22%
  • Operating margin 22% (21)
  • Earnings per share before dilution SEK 5.46 (4.66)
  • Cash flow from operating activities SEK 783 million (569)

Continued growth with robust margins

Vitec's growth strategy combines both organic expansion and strategic acquisitions. For the second quarter of 2024, we achieved a sales increase of 22%, contributing to a 20% growth for the first half of the year, aligning with our ten-year average annual growth rate of 22%.

Our focus on organic growth is underscored by our analysis of pro forma rolling 12-month revenue, a metric that reflects our current annual rate and growth. Our business units, which develop and offer niche business-critical software, operate in stable markets characterized by long-term customer relationships.

As we entered 2024, our customer base remained steady, with new sales showing caution but demonstrating strong figures in additional sales to existing customers.

In this quarter, our business unit Enova, providing balancing services in the Dutch energy grid, has significantly increased volumes. This surge is driven by the daily market needs, with the integration of more renewable energy sources into the energy mix necessitating greater balancing power. The high proportion of renewables during the summer has resulted in substantial volumes, benefiting our customers and is clearly reflected in the rise in transaction-based recurring revenues.

For the period, our EBITA increased by 17% to SEK 264 million, yielding a margin of 30%. The cash flow from operating activities also showed an improvement compared to the same period last year, with significant gains in the first half of the year. This, coupled with our healthy debt levels and available credit, ensures our preparedness for further acquisitions.

In the second quarter, we acquired Bidtheatre, a specialized vertical software company primarily supporting media agencies in Sweden. In early July, we announced the acquisition of the Swedish software company Taxiteknik, which provides innovative solutions for the taxi industry. These acquisitions bring the total to three so far this year, with more opportunities under continuous evaluation. We have also consolidated a couple of business units to optimize organizational efficiency and customer offering, hence we now present 40 business units.

I extend my best wishes for a pleasant summer to all our customers, employees, and stakeholders.

Olle Backman, CEO and President
Vitec Software Group

For more information, please contact
Olle Backman, CEO, Vitec Software Group AB (publ)
olle.backman@vitecsoftware.com, +46 70 632 89 93

Patrik Fransson, Investor Relations, Vitec Software Group AB (publ),
patrik.fransson@vitecsoftware.com, +46 76 942 85 97

About Vitec Software Group
Vitec is a leading provider of Vertical Software and has its origin and headquarters in Umeå, Sweden. Our products are developed to meet specific needs within various niche markets in society. The expertise of our employees, combined with our shared corporate culture and business model, enable continuous improvement and innovation. We grow through the successes of our companies, as well as through acquisitions. Everything we do is based on a long-term perspective. Because we are to rely on - today and tomorrow. Vitec has 1,550 employees, is listed on Nasdaq Stockholm and had net sales of SEK 2,778 million in 2023. Read more at vitecsoftware.com.

This information is information that Vitec Software Group is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-07-12 08:00 CEST.

Image Attachments
Olle Backman Vitec Software Group 2024

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.